Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision.pdf
《Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision.pdf》由会员分享,可在线阅读,更多相关《Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision.pdf(173页珍藏版)》请在三一文库上搜索。
1、Advances in Ophthalmology Rures adquireret umbraculi, etiam tremulus matrimonii libere senesceret app July 2009 Kalorama Information A division of MarketR 38 East 29th Street Sixth Floor New York, New York 10016 212.807 .2660 t 800.298.5603 t 212.807 .2676 f ADVANCES IN OPHTHALMOLOGY MARKETS IN THE
2、 TREATMENT OF EYE DISORDERS AND CORRECTIVE VISION A KALORAMA INFORMATION MARKET INTELLIGENCE REPORT Advances in Ophthalmology has been prepared by Kalorama Information. We serve business and industrial clients worldwide with a complete line of information services and research publications. Kalorama
3、 Information Market Intelligence Reports are specifically designed to aid the action-oriented executive by providing a thorough presentation of essential data and concise analysis. Author: Mountaintop Medical Publication Date: July 2009 38 East 29th Street New York, New York 10016 (800) 298-5699 Out
4、side the U.S. (212) 807-2657 FAX: (212) 807-2676 http:/www.KaloramaI E-MAIL: COPYRIGHT 2009 Kalorama Information a division of MarketR, Inc. Copyright 2006 Kalorama Information Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any pa
5、rt, is strictly prohibited. TABLE OF CONTENTS CHAPTER ONE: EXECUTIVE SUMMARY1 Overview1 Objectives, Scope, and Methodology.2 Summary Of Findings 5 Overview of Current Market Dynamics .5 Market Analysis and Forecasts7 CHAPTER TWO: INTRODUCTION AND OVERVIEW11 Overview11 History in Treating Eye Disease
6、s.12 World Demographics14 Population by Gender 17 Aging Population18 Staggering World Facts20 CHAPTER THREE: ISSUES AND TRENDS IN THE OPHTHALMOLOGY INDUSTRY.23 Overview23 Resistance to Change24 The New Technological Revolution.26 Competition: Old vs New.26 Refractive Vision Correction RVC.27 Patient
7、 Reported Outcomes for Laser in situ Keratomileusis (LASIK) Surgery28 World Economy and Refractive Surgery29 Typical Refractive Demographic 2009.30 Major Eye Diseases.30 Regulation31 Governments Role as Overseer .31 Government Mandate: Safety MDDEA-II threats and care of eyesight; and MDDEA-III the
8、eye examination. These programs involve the diagnosis, treatment and causes of the major eye disease and underscore the significance of MDDEA especially the elderly in their 70s and 80s, the most vulnerable age. The programs aim to help: prevent further deterioration, vision loss and blindness 4 Adv
9、ances in Ophthalmology Copyright 2009 Kalorama Information Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited. contain complications from secondary medical conditions reduce the rate of increases in the
10、 number people threatened get the word out to world leaders and governments like 20/20 VISON sponsored by the World Health Organization WHO. A major segment of this report deals with competitive populations of key manufacturers/companies offering a wide-range of products, technologies and treatment
11、services employed in refractive vision correction and management of eye diseases. Profiles of key manufactures are presented with in-depth descriptions with contact information status of business technology breakthroughs in ophthalmology discovery, research, product development, and clinical trials
12、market status competitive standing within their product and market niches and latest business activities. The information represented in this report is a comprehensive analysis of the eye care market globally with a special focus on the United States and selected international sectors. The year endi
13、ng December 31, 2008 was used as the base year with forecasts to the year 2013. Market statistics are given in U.S. dollars and in units where appropriate. Basis for the market analysis consists of key data, statistics; references, and information from a large data base of primary and secondary rese
14、arch sources documented in the report consisting of interviews, professional meetings; conferences; presentations; journals; consumer media radio, TV, magazines, newspapers; and Internet content involving more than 40,000 sources. Data were collected for global populations and medical providers who
15、represent the key influences in the eye care market. The market analysis is comprised of two major sectors: refractive vision correction addressing myopia, hyperopia, presbyopia, and astigmatism and major eye diseases addressing cataracts, glaucoma, AMD, retinal disorders. Within the primary sectors
16、 the analysis includes the top RVC treatment modalities traditional and advanced laser systems; RVC lens implants, and alternative surgical implants and surgical intervention for each of the major diseases retinal laser surgery, photo dynamic therapy, pneumatic thermoplasticy, capsulectomy, and trab
17、eculectomy. Competitive market shares are given for the key manufacturers of RVC treatment methodologies and for major devices and ophthalmic therapeutics employed in the management of eye diseases. Market shares are also given for Chapter One: Executive Summary 5 Copyright 2009 Kalorama Information
18、 Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited. the leading services providers optometrists/practitioners; eye care centers/clinics; specialty eye clinics/hospitals offering RVC procedures and/or t
19、reatment of eye diseases. SUMMARY OF FINDINGS Overview of Current Market Dynamics The general finding in this study reflects the same competitive dynamics in past years. Again, the market finds itself highly fragmented, competitively volatile, and ultra conservative. Drug companies still reign, and
20、treatment modalities include mostly old technology pharmaceuticals, eye glasses, contact lenses, and lesser surgical intervention. Even as technologies cross competitive boundaries, players cannot ignore the size of the market and its potential business opportunities. There is virtually unlimited de
21、mand from people with vision problems in a global population of more than 6 billion. Considering that half of the people born with normal eyesight will need corrective vision at least glasses at some stage in their lives, there is an enormous pool of customers, which continues to renew with each bir
22、th. Fulfilling this demand for both traditional and advanced refractive corrective treatment protocols will propel the ophthalmology market to become one of the largest sectors in health care over the next ten years. The ophthalmology market is faced with enormous challenges dealing with restoration
23、 of impaired vision and impaired vision impacted by disease. While traditional methodologies to restore vision are readily available; treating disease-related vision problems presents a greater challenge, especially for people that depend on traditional methods. But, the most pressing of eye care ne
24、eds is reaching less-privileged people in developing and underdeveloped countries. It is one of the most difficult socio-economic and health care challenges of this 21st Century. The major sectors in this report, refractive vision correction RVC and major eye diseases MEDs, share similar business ch
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- Advances in Ophthalmology: Markets the Treatment of Eye Disorders and Corrective Vision Ophthalmology
链接地址:https://www.31doc.com/p-3729279.html